The only way this company will turn around if they rein in the ever increasing spending, cut their over inflated wages compared to the results they have delivered so far, balance their spending according to their income, as long as they keep spending beyond their means, the dreaded threat of CRs will keep real investors away and put a lid on any SP appreciation. Under promise and over deliver. there is nothing worst than to promise share holders and then only to disappoint them.
News: AHZ Admedus Says Cardiocel 3D And Vascucel Receives European Regulatory Approval, page-72
-
- There are more pages in this discussion • 496 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$9.91 |
Change
-0.090(0.90%) |
Mkt cap ! $209.4M | |||
| Open | High | Low | Value | Volume |
| $10.00 | $10.00 | $9.65 | $70.76K | 7.202K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 300 | $9.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $9.91 | 475 | 2 |
View Market Depth
| Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
| AVR (ASX) Chart |